Similar articles

• A review of the United Kingdom Prospective Diabetes Study (UKPDS) and a discussion of the implications for patient care.

  Srimanunthiphol J, Beddow R, Arakaki R. Srimanunthiphol J, et al. Hawaii Med J. 2000 Jul;59(7):295-8, 313. Hawaii Med J. 2000. PMID: 10961040 No abstract available.
• [Prospective pioglitazone clinical trial in macrovascular events].

  Asanuma H, Kitakaze M. Asanuma H, et al. Nihon Rinsho. 2012 May;70 Suppl 3:301-8. Nihon Rinsho. 2012. PMID: 22768537 Japanese. No abstract available.
• Implications of the United Kingdom prospective diabetes study for patients with obesity and type 2 diabetes.

  Genuth S. Genuth S. Obes Res. 2000 Mar;8(2):198-201. doi: 10.1038/oby.2000.22. Obes Res. 2000. PMID: 10757207 Review. No abstract available.
• Does intensive glycemic control improve cardiovascular outcomes?

  Pendergrass M. Pendergrass M. Nat Clin Pract Endocrinol Metab. 2008 Oct;4(10):529. doi: 10.1038/ncpendmet0953. Nat Clin Pract Endocrinol Metab. 2008. PMID: 18806805 No abstract available.
• The natural history of diabetes-related complications: the UKPDS experience. United Kingdom Prospective Diabetes Study.

  Matthews DR. Matthews DR. Diabetes Obes Metab. 1999 Sep;1 Suppl 2:S7-13. doi: 10.1046/j.1463-1326.1999.0010s2007.x. Diabetes Obes Metab. 1999. PMID: 11221801 Review. No abstract available.